Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management

Summary: Neurofilament light chain (NfL) is a long-awaited blood biomarker that can provide clinically useful information about prognosis and therapeutic efficacy in multiple sclerosis (MS). There is now substantial evidence for this biomarker to be used alongside magnetic resonance imaging (MRI) an...

Descripción completa

Detalles Bibliográficos

Autores principales:	Mark S. Freedman, Sharmilee Gnanapavan, Ronald A. Booth, Peter A. Calabresi, Michael Khalil, Jens Kuhle, Jan Lycke, Tomas Olsson
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2024-03-01
Colección:	EBioMedicine
Materias:	Multiple sclerosis Neurofilament light chain Cerebrospinal fluid biomarkers Serum biomarkers
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S2352396424000057
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!